Company: uniQure
Posted by GTxRep_UniQure_Boston_1123 · March 17, 2026
Tags: strategy, launch, leadership
gene therapy and rare disease took the worst of his tenure.
unpredictable bar, surprise CRLs, moving goalposts.
UniQure up 36% is not an overreaction.
certainty is what this market needed.
trajectory changed today.
11 upvotes · 5 comments